PROGENICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN PUT, CUSIP 743187956.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN PUT, CUSIP 743187956.